BioSpace News Archive

Photocure ASA reported Hexvix®/Cysview® revenues of NOK 86.7 million in the third quarter of 2021, and EBITDA of NOK -0.2 million, following the continued successful launch in markets previously operated by Ipsen Pharma SAS.

France-based biotechnology company AlgoTherapeutix, developer of ATX01, an innovative topical treatment for the pain of peripheral neuropathy, announced that the ATX01 Phase I trial successfully reached its safety and pharmacokinetics objectives, clearing the way for Phase II development in Chemotherapy-Induced Peripheral Neuropathy.

Memgen, Inc., a clinical-stage biotechnology company developing potentially life-saving cancer immunotherapies, announced that Kevin M. Coveney, CPA, has been appointed Chief Financial Officer.

GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced US government contracts totaling approximately $1 billion (USD) to purchase sotrovimab.

ProMIS Neurosciences Inc., is pleased to announce that a second independent, third party proxy advisory firm, Institutional Shareholder Services, has recommended that shareholders vote FOR the share consolidation at the upcoming special general meeting of shareholders to be held on December 1, 2021.

The healthcare industry is plagued by a range of pressing challenges ranging from managing patient data to maintaining the supply chain of drugs.

The global electrosurgical devices market is witnessing growth through a robust competition. The market landscape is fragmented and growing costs of R&D poses major restraint to growth.

Pen needles are used in combination with pen injectors for the delivery of injectable medications. A pen needle comprises a hollow needle which is fixed in a plastic hub and connects to the injection pen.

According to the report, the global traditional Chinese medicine for skincare market was valued at US$ 3.5 Bn in 2019 and is projected to expand at a CAGR of ~8% from 2020 to 2030.

Corzo brings a 25+ year successful track record in biopharma, excelling in oncology drug development with Takeda, Sanofi Genzyme, and Eli Lilly.